OpenVSafe by OpenVAERS
Search V-safe

AMN-33523-64553

4 vaccinations 10 coded responses 26 check-ins 10 free-text entries 0 call cases
Sex
Female
Age at first dose
26-30
ZIP prefix
586 / ND
Registered
2021-03-18
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-17
    Dose 1 — Moderna
  2. 2021-03-18
    Registered in v-safe
  3. 2021-03-18
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain, Redness, Swelling · Chills, Headache, Joint pains, Muscle or body aches
    Adult check-in
  4. 2021-03-19
    Survey response — days 1–6 daily, dose 1
    MedDRA: Injection site bruising — Feeling: Good · Site: Pain, Redness, Swelling, Itching
    Free text: Bruising at injection site
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-03-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain, Itching · None
    Adult check-in
  6. 2021-03-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-03-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-03-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-03-24
    Survey response — day 7, dose 1
    MedDRA: Injection site bruising, Injection site warmth — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fatigue or tiredness
    Free text: Heat and bruising at injection site
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-03-31
    Survey response — day 14, dose 1
    MedDRA: Cough, Injection site bruising, Injection site erythema, Oropharyngeal pain, Pruritus, Rhinorrhoea, Tonsillar hypertrophy — Feeling: Good
    Free text: Enlarged tonsils with discharge - sore throat, cough and runny nose; 12 days after injection. Nearly resolved. Mild itching and redness at injection site until 10 days after injection. Injection site still discolored like a bruise.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-04-07
    Survey response — day 21, dose 1
    MedDRA: Fatigue, Muscular weakness, Nausea, Pain, Vomiting — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Nausea, vomiting, body aches, fatigue, muscle weakness (thinking a stomach bug)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-04-14
    Dose 2 — Moderna
  13. 2021-04-14
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  14. 2021-04-15
    Survey response — days 1–6 daily, dose 2
    MedDRA: Muscular weakness, Respiratory tract congestion — Feeling: Poor · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Free text: Muscle weakness, congestion
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-04-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  16. 2021-04-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  17. 2021-04-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-04-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-04-21
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-04-28
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-05-05
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-05-12
    Survey response — day 28, dose 2
    MedDRA: Headache, Primary stabbing headache — Feeling: Good
    Free text: ice pick headaches
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-05-19
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-05-28
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-07-16
    Survey response — 3 months, dose 2
    MedDRA: Injection site pain — Feeling: Fair
    Free text: Continued random injection site pain. Was unable to apply pressure to first injection site until a few weeks ago. Now random pain at site.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  26. 2021-10-13
    Survey response — 6 months, dose 2
    MedDRA: Injection site pain, Neuralgia — Feeling: Good
    Free text: Random nerve pain especially in legs. Continued pain at first injection site.
    MedDRA releases: 2024-11 · check-in free text available
  27. 2021-11-06
    Dose 3 — Moderna
  28. 2022-04-16
    Survey response — 12 months, dose 2
    MedDRA: Intermenstrual bleeding, Menstruation irregular — Feeling: Good
    Free text: Change in period regularity. Spotting 1 week and 1 week period.
    MedDRA releases: 2024-11 · check-in free text available
  29. 2022-05-08
    Health check-in — 6 months, dose 3
    Feeling: Fair
    Adult check-in
  30. 2022-09-23
    Dose 4 — Pfizer-BioNTech
  31. 2022-11-09
    Survey response — 12 months, dose 3
    MedDRA: Arthralgia, Blood cholesterol increased, Headache, Injection site discharge, Menstruation irregular, Musculoskeletal discomfort, Pain — Feeling: Fair
    Free text: Increased joint and general pain. discomfort in shoulders at injection sites. Inconsistent periods. Increased headaches, high cholesterol.
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-03-17Moderna
22021-04-14Moderna
32021-11-06Moderna No
42022-09-23Pfizer-BioNTech No

Free text

Release 5 — days 1–6 daily, dose 1

2021-03-19

Systemic reaction (other): Bruising at injection site

Release 6 — day 7, dose 1

2021-03-24

Systemic reaction (other): Heat and bruising at injection site

Release 6 — day 14, dose 1

2021-03-31

Symptoms: Enlarged tonsils with discharge - sore throat, cough and runny nose; 12 days after injection. Nearly resolved. Mild itching and redness at injection site until 10 days after injection. Injection site still discolored like a bruise.

Release 7 — day 21, dose 1

2021-04-07

Symptoms: Nausea, vomiting, body aches, fatigue, muscle weakness (thinking a stomach bug)

Release 7 — days 1–6 daily, dose 2

2021-04-15

Systemic reaction (other): Muscle weakness, congestion

Release 8 — day 28, dose 2

2021-05-12

Symptoms: ice pick headaches

Release 9 — 3 months, dose 2

2021-07-16

Symptoms: Continued random injection site pain. Was unable to apply pressure to first injection site until a few weeks ago. Now random pain at site.

Release 10 — 6 months, dose 2

2021-10-13

Symptoms: Random nerve pain especially in legs. Continued pain at first injection site.

Release 11 — 12 months, dose 2

2022-04-16

Symptoms: Change in period regularity. Spotting 1 week and 1 week period.

Release 12 — 12 months, dose 3

2022-11-09

Symptoms: Increased joint and general pain. discomfort in shoulders at injection sites. Inconsistent periods. Increased headaches, high cholesterol.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDArthralgia · · ✓
SDBlood cholesterol increased · · ✓
SDCough ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDHeadache ✓ ✓ ✓
SDInjection site bruising ✓ ✓ ✓
SDInjection site discharge · · ✓
SDInjection site erythema ✓ ✓ ✓
SDInjection site pain ✓ · ✓
SDIntermenstrual bleeding · · ✓
SDMenstruation irregular · · ✓
SDMuscular weakness ✓ ✓ ✓
SDMusculoskeletal discomfort · · ✓
SDNausea ✓ ✓ ✓
SDNeuralgia · · ✓
SDOropharyngeal pain ✓ ✓ ✓
SDPain ✓ ✓ ✓
SDPrimary stabbing headache · · ✓
SDPruritus ✓ ✓ ✓
SDRhinorrhoea ✓ ✓ ✓
SDTonsillar hypertrophy ✓ ✓ ✓
SDVomiting ✓ ✓ ✓
SROInjection site bruising ✓ ✓ ✓
SROInjection site warmth ✓ ✓ ✓
SROMuscular weakness ✓ ✓ ✓
SRORespiratory tract congestion ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release